Filing Details
- Accession Number:
- 0001140361-17-037761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-06 12:20:25
- Reporting Period:
- 2017-10-04
- Accepted Time:
- 2017-10-06 12:20:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501989 | Cytomx Therapeutics Inc. | CTMX | Pharmaceutical Preparations (2834) | 273521219 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578767 | Michael William Kavanaugh | 151 Oyster Point Blvd. Suite 400 South San Francisco CA 94080 | Cso, Head Res.&Non-Clin. Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stok | Acquisiton | 2017-10-04 | 48,368 | $4.47 | 62,285 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-04 | 48,368 | $24.34 | 13,917 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-04 | 48,368 | $0.00 | 48,368 | $4.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 48,368 | 2025-05-06 | No | 4 | M | Direct |
Footnotes
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The shares subject to the option are fully vested and exercisable.
Billionaire Hedge Funds
